Related references
Note: Only part of the references are listed.Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
Feng Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection
Xiaojing Zou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease
Muhammad Umair Khan et al.
GASTROENTEROLOGY (2021)
Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation
Ke Zhan et al.
GUT (2021)
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort
Jasmohan S. Bajaj et al.
GUT (2021)
SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19
Deheng Han et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease
Giovanni Sansoe et al.
LIVER INTERNATIONAL (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Coronavirus puts drug repurposing on the fast track
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
Review article: COVID-19 and liver disease-what we know on 1st May 2020
Isabel Garrido et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
COVID-19 and the Heart
Akbarshakh Akhmerov et al.
CIRCULATION RESEARCH (2020)
Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study
Shailendra Singh et al.
GASTROENTEROLOGY (2020)
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
Giovanni Targher et al.
GUT (2020)
COVID-19 and immunomodulation in IBD
Markus F. Neurath
GUT (2020)
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort
Meaghan M. Phipps et al.
HEPATOLOGY (2020)
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China
Xiaolong Qi et al.
HEPATOLOGY INTERNATIONAL (2020)
Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy
Amaro N. Duarte-Neto et al.
HISTOPATHOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J. Barnes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
Yijin Wang et al.
JOURNAL OF HEPATOLOGY (2020)
SARS-CoV-2 related liver impairment - perception may not be the reality
Cyriac Abby Philips et al.
JOURNAL OF HEPATOLOGY (2020)
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
Andrew M. Moon et al.
JOURNAL OF HEPATOLOGY (2020)
COVID-19: Abnormal liver function tests
Qingxian Cai et al.
JOURNAL OF HEPATOLOGY (2020)
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Dong Ji et al.
JOURNAL OF HEPATOLOGY (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
Bing Zhao et al.
PROTEIN & CELL (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
SARS-CoV-2 and viral sepsis: observations and hypotheses
Hui Li et al.
LANCET (2020)
SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19
Carlos J. Pirola et al.
LIVER INTERNATIONAL (2020)
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China
Yafei Zhang et al.
LIVER INTERNATIONAL (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
Zhengpin Wang et al.
CELLS (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Liver injury in COVID-19: management and challenges
Chao Zhang et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Clinical Features of COVID-19-Related Liver Functional Abnormality
Zhenyu Fan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Platelet gene expression and function in patients with COVID-19
Bhanu Kanth Manne et al.
BLOOD (2020)
Abnormal Liver Function Tests in Patients WithCOVID-19: Relevance and Potential Pathogenesis
Anna Bertolini et al.
HEPATOLOGY (2020)
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2020)
COVID-19 and the liver: little cause for concern
Mansoor N. Bangash et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
COVID-19 and the liver
Dinesh Jothimani et al.
JOURNAL OF HEPATOLOGY (2020)
Reply to: Correspondence relating to SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
Yijin Wang et al.
JOURNAL OF HEPATOLOGY (2020)
High rates of 30-day mortality in patients with cirrhosis and COVID-19
Massimo Iavarone et al.
JOURNAL OF HEPATOLOGY (2020)
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations
Aurelio Sonzogni et al.
LIVER INTERNATIONAL (2020)
Metabolic-associated fatty liver disease is associated with severity of COVID-19
Yu-Jie Zhou et al.
LIVER INTERNATIONAL (2020)
COVID-19 and the liver-related deaths to come
Jean-Michel Pawlotsky
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Tobias Boettler et al.
JHEP REPORTS (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich et al.
STEM CELL REVIEWS AND REPORTS (2020)
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Gong Feng et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
Tobias Boettler et al.
JHEP REPORTS (2020)
Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms
Wasim A. Dar et al.
LIVER INTERNATIONAL (2019)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury
Xiao-Jing Zhang et al.
NATURE MEDICINE (2018)
Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide
Hsi-Tien Wu et al.
EXPERIMENTAL ANIMALS (2018)
Liver - guardian, modifier and target of sepsis
Pavel Strnad et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
Javad Rasouli et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
Lijuan Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu
Carmen Peralta et al.
JOURNAL OF HEPATOLOGY (2013)
Ischaemia-reperfusion injury, in liver transplantation-from bench to bedside
Yuan Zhai et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
Marie-Luise von Bruehl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Functional Genetic Variants in DC-SIGNR Are Associated with Mother-to-Child Transmission of HIV-1
Genevieve Boily-Larouche et al.
PLOS ONE (2009)
Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-Mediated severe acute respiratory syndrome coronavirus entry
Dong P. Han et al.
JOURNAL OF VIROLOGY (2007)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases
TN Chau et al.
HEPATOLOGY (2004)
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
SA Jeffers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
JP Gardner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
